IDPH--Positive preliminary results for pivotal trial of ID

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
IDPH--Positive preliminary results for pivotal trial of ID

An SI Board Since June 1996

Posts	SubjectMarks	Bans	Symbol
1762	27	0	IDPH

Emcee: Roudy	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1537	Richard, That was a quintuple negative - Guiness material. Count them! "	Maurice Winn	-	4/12/1998
1536	Maurice: I am interested in CLTR, IDPH, and TCLN. Have owned IDPH on at lea	scaram(o)uche	-	4/12/1998
1535	BobL, It's interesting how time is improving the effectiveness of Rituxan i	Maurice Winn	-	4/11/1998
1534	It's too bad even in this age that patients aren't really in control of	Bob L	-	4/10/1998
1533	They didn't steer us towards CHOP. That was the preferred treatment within	Maurice Winn	-	4/10/1998
1532	Glad you enjoy my Yahoo posts, Maurice. I'm not so popular over there. For	Bob L	-	4/10/1998
1531	cancernet.nci.nih.gov Thanks BobLLL from Yahoo for the reference and comments:	Maurice Winn	-	4/10/1998
1530	Fair enough Bob, blind buying of Techniclone by IDEC wouldn't be too bright	Maurice Winn	-	4/10/1998
1529	As a shareholder in IDEC, CLTR, and TCLN, I hope to win no matter which way. &l	Bob L	-	4/9/1998
1528	Thanks for the statistical boost BobL, Meanwhile, over on the Techniclone	Maurice Winn	-	4/9/1998
1527	Hello AJ! I suspect that the clinical judgement of the risk of using Rituxan a	Maurice Winn	-	4/9/1998
1526	Maurice, I agree with everything in that post re. small but significant chance	A.J. Mullen	-	4/8/1998
1525	Since you are reduced to taking sample sizes of one, here is another. And this	Bob L	-	4/4/1998
1524	Maurice, Good to hear your son is done with treatment. With regard to your mat	DMB	1	4/3/1998
1523	Well, statistics with a sample of one beats a sample of none! If there are doz	Maurice Winn	-	4/2/1998
1522	The large majority of patients with low grade lymphoma at any one time are doin	DMB	1	4/1/1998
1521	So, what's going on? 50,000 people per year getting NHL in USA. Half of t	Maurice Winn	-	4/1/1998
1520	nejm.org Some more on gene therapy and vaccines. Thanks for the reference PB.	Maurice Winn	-	3/16/1998
1519	Maurice, while you wait to see if Rick wants to add anything on your questions,	Maurice Winn	-	3/15/1998
1518	Thanks for the comments Rick. While the tumor might recur wearing different cl	Maurice Winn	-	3/14/1998
1517	Longster, I noticed your comments in Yahoo. You are partly right. Yes, this	Maurice Winn	-	3/14/1998
1516	Maurice: Sorry, don't follow this thread any longer, so just now saw your	scaram(o)uche	-	3/12/1998
1515	DMB, thanks. Regarding the mechanism by which lymphoma cells die from Rituxan,	Maurice Winn	-	3/11/1998
1514	Thanks for the follow up. I would have been very surprised had you found someon	DMB	1	3/11/1998
1513	PB, It seemed to me that if Rituxan makes you susceptible to tuberculosis due t	Maurice Winn	-	3/9/1998

Go to reply# or date (mm/dd/yy):